Angelo De Blasio

An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia.

V. Petrizzi, E. Vismara, M. Montillo, 2011, Blood.